Limbal stem cell deficiency is a condition in which the cornea loses its ability to renew itself, leading to clouded vision, chronic pain, light sensitivity, and sometimes blindness. The cornea normally stays clear thanks to a population of stem cells living at the limbus, a narrow ring where the clear cornea meets the white of the eye. When those cells are destroyed or exhausted by injury, disease, or genetic conditions, the neighboring conjunctival tissue creeps over the corneal surface, replacing the transparent epithelium with opaque, blood-vessel-laden tissue. Over six million people worldwide are affected by corneal blindness, and limbal stem cell deficiency is one of the main causes.1PubMed Central. Limbal Stem Cell Deficiency and Treatment with Stem Cell Transplantation
What Limbal Stem Cells Actually Do
Your cornea is the only transparent tissue on the body’s surface, and keeping it that way is a demanding job. The outermost layer of the cornea, the epithelium, constantly sheds and replaces itself in a cycle that takes roughly a week. That renewal depends on stem cells tucked into the basal layer of the limbus. These cells are normally quiet, dividing only when needed, but they have enormous proliferative capacity when called upon. They also lack the markers of mature corneal cells, expressing instead a set of progenitor markers that distinguish them from the differentiated cells they produce.2PubMed Central. Limbal stem cells: Central concepts of corneal epithelial homeostasis
The limbus is not just a storage depot for stem cells. It is a specialized niche environment containing stromal fibroblasts, melanocytes, immune cells, and a unique basement membrane, all of which help maintain the stem cells and coordinate regeneration.3PubMed Central. Limbal stem cells: identity, developmental origin, and therapeutic potential When any part of that niche is damaged, the stem cells may fail even if some of them survive. This is why LSCD can develop not only from outright destruction of the limbus but also from chronic inflammation that degrades the supporting environment.
What Causes Limbal Stem Cell Deficiency
The causes split broadly into injuries, diseases, and inherited conditions. Chemical burns, especially alkali burns, are the single most common trigger. Alkali agents penetrate the eye deeply and destroy the limbal niche almost instantly, which is why even aggressive emergency irrigation cannot always prevent LSCD from developing afterward. Thermal burns and radiation injury can do the same. Severe contact-lens overwear is another acquired cause: years of low-grade oxygen deprivation and mechanical friction can gradually erode the limbal stem cell population.4PubMed Central. A Review of Contact Lens-Induced Limbal Stem Cell Deficiency
On the disease side, Stevens-Johnson syndrome is one of the most devastating causes. This severe drug reaction targets mucous membranes throughout the body, including the ocular surface, and the resulting scarring often wipes out the limbal niche entirely. Long-standing vernal keratoconjunctivitis, a chronic allergic eye disease most common in young males in warm climates, can also lead to LSCD over time.5Cornea. Vernal Keratoconjunctivitis With Limbal Stem Cell Deficiency Other inflammatory conditions such as ocular cicatricial pemphigoid, chronic graft-versus-host disease, and certain infections round out the list of disease-related causes.
Congenital aniridia, a genetic condition in which the iris fails to develop fully, is the most recognized inherited cause. The same developmental pathway that builds the iris also supports the limbal stem cell niche, so people with aniridia commonly develop progressive LSCD through childhood and adolescence even without any external injury.
How LSCD Feels and What It Looks Like
The hallmark symptoms are pain, light sensitivity, tearing, and blurred vision that worsens over time.6PubMed Central. Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies The severity depends on how much of the limbus is affected. In partial LSCD, where only a sector of the limbus has failed, you might notice intermittent irritation and mild haziness at the edge of your vision. In total LSCD, the entire cornea becomes covered with vascularized conjunctival tissue, turning it opaque and deeply reducing or eliminating useful vision.7PubMed Central. Concise review: limbal stem cell deficiency, dysfunction, and distress
Under the slit lamp, an ophthalmologist can see new blood vessels growing across the corneal surface, a process called neovascularization. The cornea may also show irregular, hazy patches where conjunctival epithelium has replaced corneal epithelium. Recurrent erosions and persistent epithelial defects are common, causing that gritty, foreign-body sensation that many patients describe. The appearance of the eye can also change cosmetically: the normally white-and-clear boundary between sclera and cornea becomes blurred, and the cornea itself takes on a grayish, fleshy look.
Quality-of-life studies confirm what patients report anecdotally. Pain and disfigurement together impose a greater burden on well-being than vision loss alone, and bilateral disease is substantially worse than unilateral.8PubMed Central. Standard Gamble to Derive Utility Health States for Limbal Stem Cell Deficiency This matters clinically because it means treatment decisions should weigh comfort and appearance alongside visual acuity, especially when vision recovery is uncertain.
How Doctors Diagnose and Stage It
Diagnosis typically starts at the slit lamp, where an experienced corneal specialist can spot the telltale signs of conjunctivalization and neovascularization. But clinical examination alone can miss early or sectoral disease, so several additional tools are used.
Impression cytology is the traditional confirmatory test. A small piece of filter paper or membrane is pressed gently against the corneal surface to pick up the outermost cells. Those cells are then stained for specific markers. Normal corneal epithelial cells express certain cytokeratins that conjunctival cells do not. Finding conjunctival markers like cytokeratin 13 on the corneal surface confirms that conjunctival tissue has invaded, which is the defining feature of LSCD.9PubMed Central. Cytokeratin 13 is a new biomarker for the diagnosis of limbal stem cell deficiency This technique can also help localize which sector of the limbus has failed in partial cases.10PubMed. Analysis of limbal stem cell deficiency by corneal impression cytology
In vivo confocal microscopy offers a non-invasive alternative. It can visualize individual cells on the corneal surface at high magnification without touching the eye, and it shows strong agreement with impression cytology results.11PubMed. In vivo confocal microscopy in diagnosis of limbal stem cell deficiency Optical coherence tomography of the limbus and central cornea adds a complementary perspective, providing cross-sectional views that help assess the depth and extent of damage.12PubMed. In vivo confocal microscopy and optical coherence tomography as innovative tools for the diagnosis of limbal stem cell deficiency
A global consensus panel defined three stages of LSCD based on how much of the cornea and limbus is involved. The critical threshold is whether the central cornea, specifically the central five millimeters over the visual axis, is affected. Stage I disease spares the visual axis; Stage II involves it; and Stage III represents total LSCD where the entire corneal surface is conjunctivalized. Whether more or less than half of the limbal stem cells remain intact is another key consideration. Staging guides treatment, because early-stage disease may respond to conservative measures while advanced disease typically requires surgery.13PubMed Central. Global consensus on the definition, classification, diagnosis and staging of limbal stem cell deficiency
Conservative and Early-Stage Management
Before any surgery is considered, the underlying cause must be addressed and the ocular surface stabilized. Inflammation is the enemy of limbal stem cells, and any active inflammatory process needs to be controlled first. Limbal transplantation is actually contraindicated when severe dry eye is present, so moisture on the ocular surface has to be restored or supplemented as a prerequisite.14PubMed. Contemporary limbal stem cell transplantation – a review
For mild or partial LSCD, preservative-free lubricating drops, anti-inflammatory eye drops, and scleral contact lenses that vault over the damaged cornea and provide a fluid reservoir can often manage symptoms and slow progression. Autologous serum tears, made from the patient’s own blood, supply growth factors that support the remaining stem cells. These measures are not curative, but they can keep the ocular surface functional for years in cases where enough limbal stem cells remain.
Surgical Treatment When Only One Eye Is Affected
Unilateral LSCD offers a significant advantage: the healthy fellow eye can serve as a donor. Because the tissue comes from the same person, there is no risk of immune rejection and no need for lifelong immunosuppressive drugs.
A systematic review of autologous limbal stem cell transplantation found that, across all techniques and at a median follow-up of just under two years, the anatomical success rate was about 69% and functional success (meaning meaningful vision improvement) was about 60%, with no serious complications in donor eyes.15PubMed. Autologous limbal stem cell transplantation: a systematic review of clinical outcomes with different surgical techniques But not all techniques performed equally. Two newer approaches, simple limbal epithelial transplantation (SLET) and conjunctival-limbal autograft (CLAu), showed anatomical success rates near 80% and functional success rates around 70%, both significantly better than the older technique of cultivated limbal epithelial transplantation (CLET) performed with autologous tissue.15PubMed. Autologous limbal stem cell transplantation: a systematic review of clinical outcomes with different surgical techniques
SLET has become popular in part because it requires only a tiny biopsy from the healthy eye, roughly one to two clock hours of limbal tissue, which is divided into small pieces and spread across an amniotic membrane placed on the affected cornea. A study of a glueless version of SLET reported clinical success in about 82% of cases at six months, with over half of patients improving to Stage 0, meaning no detectable LSCD remained.16PubMed. Midterm Outcomes of Autologous Glueless Simple Limbal Epithelial Transplantation for Unilateral Limbal Stem Cell Deficiency Its minimal donor-site impact makes it especially attractive when surgeons want to preserve as much of the healthy eye’s limbus as possible.
Treatment Options for Bilateral Disease
When both eyes are affected, there is no healthy fellow eye to borrow from, and the treatment landscape becomes more complex. The tissue must come from another person (a living relative, an unrelated donor, or cadaveric tissue) or from a non-ocular source entirely.
Allogenic limbal transplantation, using donor tissue from another person, can restore the corneal surface, but it carries the risk of graft rejection. Systemic immunosuppression is typically required for years. Oral cyclosporine is the most commonly used agent, though mycophenolate mofetil and tacrolimus have also shown good results in some studies.17PubMed Central. Systemic Immunosuppression for Limbal Allograft and Allogenic Limbal Epithelial Cell Transplantation The need for long-term immunosuppression, with its attendant risks of infection and organ toxicity, is a real drawback, particularly for younger patients who might need these drugs for decades.
An alternative that sidesteps immune rejection is cultivated oral mucosal epithelial transplantation, or COMET. In this procedure, a small biopsy is taken from the inside of the patient’s own cheek. The cells are grown in the lab on a substrate and then transplanted onto the damaged cornea. Because the tissue is autologous, systemic immunosuppression is not needed.18PubMed Central. Allogenic Cultured Limbal Epithelial Transplantation and Cultivated Oral Mucosal Epithelial Transplantation in Limbal Stem Cells Deficiency: A Comparative Study COMET has been performed in humans since 2004 and has shown the ability to restore the ocular surface and improve function in difficult bilateral cases, including those caused by Stevens-Johnson syndrome.19PubMed. Outcomes of Cultivated Oral Mucosal Epithelial Transplantation in Eyes With Chronic Stevens-Johnson Syndrome Sequelae20PubMed Central. Ex vivo cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: a review The trade-off is that graft survival rates are somewhat lower compared to allogenic limbal transplants, and the corneal surface rebuilt with oral mucosal cells may never achieve the same optical clarity as one rebuilt with true limbal-derived epithelium.
The Keratoprosthesis Option
For patients with end-stage disease who have failed biological grafts or whose ocular surface is too scarred to support any epithelial transplant, an artificial cornea (keratoprosthesis) can be a last resort. The Boston keratoprosthesis type I is the most widely used device. A systematic review of its use after severe chemical injury found that vision improved to at least 20/200 in over 93% of eyes after implantation, and about 64% maintained that level of vision at a mean follow-up of roughly two years.21PubMed. Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review The device itself was retained in about 89% of recipients.
These numbers are encouraging, but keratoprostheses require lifelong monitoring and daily antibiotic drops to prevent infection. Complications including glaucoma, retroprosthetic membrane formation, and device extrusion are not uncommon over time. The device works best in patients whose retina and optic nerve are still healthy but whose corneal surface is beyond biological repair.
What Affects Prognosis
The original cause of LSCD matters for how well treatment works. Inflammatory conditions like Stevens-Johnson syndrome carry the worst prognosis among all LSCD causes, largely because the ongoing inflammatory drive can continue to attack transplanted tissue.22PubMed Central. Update on limbal stem cell transplantation Chemical burns, while devastating, tend to be one-time events, and if the inflammation is controlled before surgery, outcomes are generally better. Aniridia-related LSCD is somewhere in between: the underlying genetic defect persists, so progressive loss of transplanted cells can occur over years, sometimes requiring repeat procedures.
Other factors influencing success include the severity and duration of disease before treatment, the health of the eyelids and tear film, and whether any prior surgeries have been performed. A dry, scarred ocular surface is hostile to any transplant, which is why surgeons often spend months optimizing the surface environment before attempting stem cell surgery.
LSCD in Children
Pediatric LSCD deserves separate attention because children face a unique risk that adults do not: amblyopia. If a child’s visual axis is blocked by an opaque cornea during the critical years of visual development, the brain may never learn to use that eye properly, even if the cornea is later cleared. This makes timely treatment especially urgent.23PubMed. Pediatric limbal stem cell deficiency: An overview of a rarely studied pathology
While chemical injuries cause LSCD in children just as they do in adults, congenital conditions like aniridia and immunological disorders like Stevens-Johnson syndrome play a proportionally larger role in the pediatric population. Viral infections can also be triggers: a case report documented LSCD developing in a ten-year-old child after chickenpox, with full 360-degree conjunctivalization and neovascularization appearing two months after the systemic illness resolved.24PubMed Central. Limbal stem cell deficiency: a dreaded complication of chickenpox in children
There is a preference for minimally invasive surgical approaches in children, given their long life expectancy and the cumulative risk of complications from aggressive procedures or long-term immunosuppression.23PubMed. Pediatric limbal stem cell deficiency: An overview of a rarely studied pathology SLET, which requires only a small biopsy from the donor eye, has been increasingly used in the pediatric setting for exactly this reason.
Emerging Cell Therapies
The most active frontier in LSCD research involves growing transplantable cells in the lab. Cultivated autologous limbal epithelial cell (CALEC) transplantation uses a small biopsy from the patient’s own limbus, expands the cells in culture, and applies them to the damaged eye. A recent phase I/II clinical trial of a manufacturing protocol developed entirely without animal products, serum, or antibiotics reported a complete success rate of about 77% at 18 months, with an additional 15% achieving partial success based on reduction in symptoms or neovascularization.25Nature Communications. Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency This xenobiotic-free approach is significant because earlier lab protocols used animal-derived feeder cells or serum, raising regulatory and safety concerns for clinical translation.
Looking further ahead, induced pluripotent stem cells (iPSCs) could theoretically eliminate the need for any limbal biopsy at all. Researchers have developed a method to produce limbal-stem-cell-like cells from iPSCs derived from bone marrow cells, achieving high-purity results in about twelve days. These cells can be seeded onto amniotic membrane or a biodegradable fibrin gel for transplantation.26PubMed. An Optimized Method to Produce Human-Induced Pluripotent Stem Cell-Derived Limbal Stem Cells Easily Adaptable for Clinical Use This approach is still preclinical, but it could eventually benefit patients with bilateral LSCD who have no limbal tissue available for biopsy, removing the dilemma of choosing between allogenic tissue (with its rejection risk) and oral mucosal cells (with their lower optical quality).
Why the Conjunctival Takeover Is Not Just Passive
For a long time, conjunctivalization was understood as a simple matter of neighboring tissue filling a vacuum. Without limbal stem cells to maintain the corneal epithelium, conjunctival cells migrated in because nothing was stopping them. But recent research using lineage-tracing techniques suggests the process is more dynamic than that. Conjunctival cells that invade the cornea do not all behave the same way. Some produce goblet cells (the mucus-secreting cells normally found in the conjunctiva), while others actually adopt certain cornea-like characteristics. These different outcomes appear to be driven by environmental signals, including factors released by corneal stromal cells and physical cues from the corneal matrix itself.27PubMed. Mechanistic insights into conjunctivalization in limbal stem cell deficiency using a lineage tracing approach Interestingly, the invading cells seem to arise from already-differentiated conjunctival cells rather than from conjunctival stem cells, which challenges older assumptions about how the takeover works. Understanding these mechanisms could eventually lead to therapies that modify the conjunctival invasion rather than simply trying to replace the lost stem cells.